RAD52 and systemic lupus erythematosus: Rad52-mediated Sμ–σδ CSR is required to mount an IgD-specific antibody response and is upregulated in systemic lupus erythematosus (SLE) patients and lupus mice, leading to high levels of total IgD and antinuclear antigen IgD autoantibodies.